ARWR vs TECH · rev $829.4M vs P/E 65, rev $1.22B
Arrowhead Pharmaceuticals Inc (ARWR) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ARWR currently screens at market cap $10.59B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ARWR and TECH stock pages for the full models.
Not investment advice.